Back to Report Store Home

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly.

  • Published: Oct-2011
  • Report Code: GBIHC116MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Biomarkers in Drug Discovery, Global, Biomarkers Facilitating Quick Turnover of Drugs, 2011

Figure 2: Biomarkers in Drug Discovery, Global Biomarkers Market, Revenue Forecast ($bn) 2002-2017

Figure 3: Biomarkers in Drug Discovery, Global, Commonly Identified Biomarkers, 2011

Figure 4: Biomarkers in Drug Discovery, Global, History of Biomarkers, 2011

Figure 5: Biomarkers in Drug Discovery, Global, Biomarkers Classification, Disease and Drug-related Biomarkers, 2011

Figure 6: Biomarkers in Drug Discovery, Global, Biomarker Categories, 2011

Figure 7: Biomarkers in Drug Discovery, Global, Types of Biomarkers, 2011

Figure 8: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Positive), 2011

Figure 9: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Positive), 2011

Figure 10: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Negative), 2011

Figure 11: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail (False Negative or Positive), 2011

Figure 12: Biomarkers in Drug Discovery, Global, Reasons Surrogate Endpoint Fail , 2011

Figure 13: Biomarkers in Drug Discovery, Global, Biomarker Discovery and Validation Process, 2009

Figure 14: Biomarkers in Drug Discovery, Global, General Application of Biomarkers, 2010

Figure 15: Biomarkers in Drug Discovery, Global, Role of Biomarkers in Drug Discovery and Development, 2011

Figure 16: Biomarkers in Drug Discovery, Global, Drug Discovery Process, 2011

Figure 17: Biomarkers in Drug Discovery, Global, Application of Biomarkers in Diagnosis, 2011

Figure 18: Biomarkers in Drug Discovery, Global, Potential Impact of Biomarkers on Disease States, 2011

Figure 19: Biomarkers in Drug Discovery, Global, Application of Biomarkers in Population Genetic Studies, 2011

Figure 20: Biomarkers in Drug Discovery, Global, Role of Biomarkers in Risk Assessment, 2011

Figure 21: Biomarkers in Drug Discovery, Global, Biomarkers Accelerate the Drug Discovery Process, 2011

Figure 22: Biomarkers in Drug Discovery, Global, Adoption of Biomarkers by Top Companies in Drug Discovery, 2011

Figure 23: Biomarkers in Drug Discovery, Global, Case Study, 2011

Figure 24: Biomarkers in Drug Discovery, Global Biomarkers Market, Revenue Forecast ($bn), 2002-2017

Figure 25: Biomarkers in Drug Discovery, Global Biomarkers Market, Market Segmentation by Therapy Area, 2011

Figure 26: Biomarkers in Drug Discovery, Global Biomarkers Drug Discovery Market, Revenue Forecast ($bn), 2002-2017

Figure 27: Biomarkers in Drug Discovery, Biomarkers Molecular Diagnostics Market, Revenue Forecast ($bn), 2002-2010

Figure 28: Biomarkers in Drug Discovery, Global Others Market, Revenue Forecast ($bn), 2002-2017

Figure 29: Biomarkers in Drug Discovery, Global Biomarkers Market Segmentation, 2011

Figure 30: Biomarkers in Drug Discovery, Global, Market Drivers and Restrains, 2011

Figure 31: Biomarkers in Drug Discovery, Global, Integration of ‘Omics’ Drive Global Biomarker Market, 2011

Figure 32: Biomarkers in Drug Discovery, Global, Biomarkers Fulfill Unmet Needs of Conventional Drug Discovery Methods, 2011

Figure 33: Biomarkers in Drug Discovery, Global, Reasons for Attrition, 2011

Figure 34: Biomarkers in Drug Discovery, Global, Biomarkers Technology Adoption Framework, 2011

Figure 35: Biomarkers in Drug Discovery, Global, Company Profile – Quest Diagnostics, 2011

Figure 36: Biomarkers in Drug Discovery, Quest Diagnostics, SWOT Analysis, 2011

Figure 37: Biomarkers in Drug Discovery, Global, Company Profile – Life Technologies, 2011

Figure 38: Biomarkers in Drug Discovery, Life Technologies, SWOT Analysis, 2011

Figure 39: Biomarkers in Drug Discovery, Global, Company Profile – Vermillion, 2011

Figure 40: Biomarkers in Drug Discovery, Vermillion, SWOT Analysis, 2011

Figure 41: Biomarkers in Drug Discovery, Global, Company Profile – BGMedicine, 2011

Figure 42: Biomarkers in Drug Discovery, BGMedicine, SWOT Analysis, 2011

Figure 43: Biomarkers in Drug Discovery, Global, Company Profile – Menarini, 2011

Figure 44: Biomarkers in Drug Discovery, Menarini, SWOT Analysis, 2011

Figure 45: Biomarkers in Drug Discovery, Global, Company Profile – Abbott, 2011

Figure 46: Biomarkers in Drug Discovery, Abbott, SWOT Analysis, 2011

Figure 47: Biomarkers in Drug Discovery, Global, Company Profile – Roche, 2011

Figure 48: Biomarkers in Drug Discovery, Roche, SWOT Analysis, 2011

Figure 49: Biomarkers in Drug Discovery, Global, Company Profile-Genentech, 2011

Figure 50: Biomarkers in Drug Discovery, Genentech, SWOT Analysis, 2011

Figure 51: Biomarkers in Drug Discovery, Global, Company Profile – Affymetrix, 2011

Figure 52: Biomarkers in Drug Discovery, Affymetrix, SWOT Analysis, 2011

Figure 53: Biomarkers in Drug Discovery, Global, Company Profile Amgen, 2011

Figure 54: Biomarkers in Drug Discovery, Amgen, SWOT Analysis, 2011

Figure 55: Biomarkers in Drug Discovery, Global, Geographic Landscape – Global Biomarkers Market, 2011

Figure 56: Biomarkers in Drug Discovery, Global, Pipeline Analysis by Phase, 2010

Figure 57: Biomarkers in Drug Discovery, Global, Pipeline Analysis by Therapeutic Class, 2011

Figure 58: Biomarkers in Drug Discovery, Global, Pipeline Analysis by Geography, 2011

Figure 59: Biomarkers in Drug Discovery, Global, Strategic Consolidations by Deal Type, 2010-2011

Figure 60: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Mergers and Acquisitions by Geography (%), 2010-2011

Figure 61: Biomarkers in Drug Discovery, Global, Strategic Consolidations, Licensing Agreement Deals by Geography (%), 2010-2011

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards